questionText: To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the effectiveness of the Orphan Drug Regulations in stimulating innovation in treatments for pancreatic cancer.
answerText: The Human Medicines Regulations include specific incentives to support orphan medicines, designed to encourage the development of medicines for rare diseases. The regulations enable the Medicines and Healthcare products Regulatory Agency (MHRA) to grant o...
heading: Pancreatic Cancer: Orphan Drugs